ReP USP - Resultado da busca

Artigo de periodico
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments (2022)
Bayer, Hugo; Stern, Cristina A. J.; Troyner, Fernanda; Gazarini, Lucas; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.
Source: Neuropharmacology. Unidade: FMRP
Subjects: COMPORTAMENTO, CANABINOIDES, TRANSTORNOS DA MEMÓRIA, FARMACOTERAPIA, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAYER, Hugo et al. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, v. 205, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108913. Acesso em: 18 nov. 2024.
APA
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2022). Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, 205, 1-11. doi:10.1016/j.neuropharm.2021.108913
NLM
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Vancouver
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Artigo de periodico
Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
Sartim, Ariandra Guerini; Marques, J.; Silveira, Kennia Moura; Nunes, Pedro Henrique Gobira; Guimarães, Francisco Silveira ; Wegener, G.; Wegener, Sâmia Regiane Lourenço Joca
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, COMPORTAMENTO ANIMAL, CANABINOIDES, DEPRESSÃO, HIPOCAMPO, ATIVIDADE MOTORA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 18 nov. 2024.
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Artigo de periodico
Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats (2021)
Estela, Airam Nicole Vivanco; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida ; Nascimento, Glauce Crivelaro do
Source: Neuropharmacology. Unidades: FORP, FMRP
Subjects: CANABINOIDES, ANALGÉSICOS, ANTICONVULSIVANTES, DOR FACIAL, NOCICEPTIVIDADE, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTELA, Airam Nicole Vivanco et al. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108700. Acesso em: 18 nov. 2024.
APA
Estela, A. N. V., Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., & Nascimento, G. C. do. (2021). Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108700
NLM
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Vancouver
Estela ANV, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108700
Artigo de periodico
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? (2021)
Salviato, Beatriz Zanutto; Raymundi, Ana Maria; Silva, Thiago Rodrigues da; Salemme, Bruna Wuilleumier; Sohn, Jeferson Machado Batista; Araújo, Fabiano Soares; Guimarães, Francisco Silveira ; Bertoglio, Leandro José; Stern, Cristina Aparecida
Source: Neuropharmacology. Unidade: FMRP
Subjects: DIFERENÇAS SEXUAIS (PSICOGÊNESE), CANABINOIDES, ANSIOLÍTICOS, ANSIEDADE, NEUROTRANSMISSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALVIATO, Beatriz Zanutto et al. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?. Neuropharmacology, v. 196, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108684. Acesso em: 18 nov. 2024.
APA
Salviato, B. Z., Raymundi, A. M., Silva, T. R. da, Salemme, B. W., Sohn, J. M. B., Araújo, F. S., et al. (2021). Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? Neuropharmacology, 196. doi:10.1016/j.neuropharm.2021.108684
NLM
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Vancouver
Salviato BZ, Raymundi AM, Silva TR da, Salemme BW, Sohn JMB, Araújo FS, Guimarães FS, Bertoglio LJ, Stern CA. Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects? [Internet]. Neuropharmacology. 2021 ; 196[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108684
Artigo de periodico
Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy (2021)
Perez, Matheus; Cartarozzi, Luciana Politti; Chiarotto, Gabriela Bortolança; Guimarães, Francisco Silveira ; Oliveira, Alexandre Leite Rodrigues de
Source: Neuropharmacology. Unidades: EEFERP, FMRP
Subjects: AXÔNIOS, CANABINOIDES, NEURÔNIOS MOTORES, NERVOS PERIFÉRICOS, NERVO CIÁTICO, NERVOS ESPINHAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, v. 197, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108726. Acesso em: 18 nov. 2024.
APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Guimarães, F. S., & Oliveira, A. L. R. de. (2021). Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy. Neuropharmacology, 197. doi:10.1016/j.neuropharm.2021.108726
NLM
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Guimarães FS, Oliveira ALR de. Short and long-term neuroprotective effects of cannabidiol after neonatal peripheral nerve axotomy [Internet]. Neuropharmacology. 2021 ; 197[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108726
Artigo de periodico
S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors (2019)
Tosta, Cristina Luz; Silote, Gabriela Pandini ; Fracalossi, Maria Paula; Sartim, Ariandra Guerini ; Andreatini, Roberto; Wegener, Sâmia Regiane Lourenço Joca ; Beijamini, Vanessa
Source: Neuropharmacology. Unidade: FCFRP
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO, CÓRTEX PRÉ-FRONTAL, ÓXIDO NÍTRICO, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOSTA, Cristina Luz et al. S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors. Neuropharmacology, v. 144, p. 233-243, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.10.039. Acesso em: 18 nov. 2024.
APA
Tosta, C. L., Silote, G. P., Fracalossi, M. P., Sartim, A. G., Andreatini, R., Wegener, S. R. L. J., & Beijamini, V. (2019). S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors. Neuropharmacology, 144, 233-243. doi:10.1016/j.neuropharm.2018.10.039
NLM
Tosta CL, Silote GP, Fracalossi MP, Sartim AG, Andreatini R, Wegener SRLJ, Beijamini V. S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors [Internet]. Neuropharmacology. 2019 ; 144 233-243.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.10.039
Vancouver
Tosta CL, Silote GP, Fracalossi MP, Sartim AG, Andreatini R, Wegener SRLJ, Beijamini V. S-ketamine reduces marble burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors [Internet]. Neuropharmacology. 2019 ; 144 233-243.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.10.039
Artigo de periodico
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks (2019)
Viana, Thércia G.; Bastos, Juliana R.; Costa, Rayssa B.; Hott, Sara Cristina; Mansur, Frederico S.; Coimbra, Cândido C.; Resstel, Leonardo Barbosa Moraes; Aguiar, Daniele C.; Moreira, Fabrício A.
Source: Neuropharmacology. Unidade: FMRP
Subjects: TRANSTORNO DO PÂNICO, RESPOSTAS EMOCIONAIS, HIPOTÁLAMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIANA, Thércia G. et al. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks. Neuropharmacology, v. 148, p. 284-290, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.01.022. Acesso em: 18 nov. 2024.
APA
Viana, T. G., Bastos, J. R., Costa, R. B., Hott, S. C., Mansur, F. S., Coimbra, C. C., et al. (2019). Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks. Neuropharmacology, 148, 284-290. doi:10.1016/j.neuropharm.2019.01.022
NLM
Viana TG, Bastos JR, Costa RB, Hott SC, Mansur FS, Coimbra CC, Resstel LBM, Aguiar DC, Moreira FA. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks [Internet]. Neuropharmacology. 2019 ; 148 284-290.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.01.022
Vancouver
Viana TG, Bastos JR, Costa RB, Hott SC, Mansur FS, Coimbra CC, Resstel LBM, Aguiar DC, Moreira FA. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks [Internet]. Neuropharmacology. 2019 ; 148 284-290.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.01.022
Artigo de periodico
Antidepressant-like effect of losartan involves TRKB transactivationfrom angiotensin receptor type 2 (AGTR2) and recruitment of FYN (2018)
Diniz, Cassiano R. A. F.; Casarotto, Plinio C.; Fred, Senem M.; Biojone, Caroline; Castrén, Eero; Joca, Sâmia Regiane Lourenço
Source: Neuropharmacology. Unidade: FCFRP
Subjects: ANGIOTENSINA II, ANTIDEPRESSIVOS, RECEPTORES DE ANGIOTENSINA, PROTEÍNAS PROTO-ONCOGÊNICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Cassiano R. A. F. et al. Antidepressant-like effect of losartan involves TRKB transactivationfrom angiotensin receptor type 2 (AGTR2) and recruitment of FYN. Neuropharmacology, v. 135, p. 163-171, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.03.011. Acesso em: 18 nov. 2024.
APA
Diniz, C. R. A. F., Casarotto, P. C., Fred, S. M., Biojone, C., Castrén, E., & Joca, S. R. L. (2018). Antidepressant-like effect of losartan involves TRKB transactivationfrom angiotensin receptor type 2 (AGTR2) and recruitment of FYN. Neuropharmacology, 135, 163-171. doi:10.1016/j.neuropharm.2018.03.011
NLM
Diniz CRAF, Casarotto PC, Fred SM, Biojone C, Castrén E, Joca SRL. Antidepressant-like effect of losartan involves TRKB transactivationfrom angiotensin receptor type 2 (AGTR2) and recruitment of FYN [Internet]. Neuropharmacology. 2018 ; 135 163-171.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.03.011
Vancouver
Diniz CRAF, Casarotto PC, Fred SM, Biojone C, Castrén E, Joca SRL. Antidepressant-like effect of losartan involves TRKB transactivationfrom angiotensin receptor type 2 (AGTR2) and recruitment of FYN [Internet]. Neuropharmacology. 2018 ; 135 163-171.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.03.011
Artigo de periodico
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling (2018)
Fogaça, Manoela Viar; Campos, Alline Cristina de; Coelho, Ludmila Daniel ; Duman, Ronald Stanton; Guimarães, Francisco Silveira
Source: Neuropharmacology. Unidade: FMRP
Subjects: NEUROFARMACOLOGIA, ANSIEDADE, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOGAÇA, Manoela Viar et al. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology, v. 135, p. 22-33, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.03.001. Acesso em: 18 nov. 2024.
APA
Fogaça, M. V., Campos, A. C. de, Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018). The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology, 135, 22-33. doi:10.1016/j.neuropharm.2018.03.001
NLM
Fogaça MV, Campos AC de, Coelho LD, Duman RS, Guimarães FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling [Internet]. Neuropharmacology. 2018 ; 135 22-33.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.03.001
Vancouver
Fogaça MV, Campos AC de, Coelho LD, Duman RS, Guimarães FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling [Internet]. Neuropharmacology. 2018 ; 135 22-33.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.03.001
Artigo de periodico
Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative (2018)
Perez, Matheus; Cartarozzi, Luciana Politti; Chiarotto, Gabriela Bortolança; Oliveira, Simone Alves de; Guimarães, Francisco Silveira; Oliveira, Alexandre Leite Rodrigues de
Source: Neuropharmacology. Unidade: FMRP
Subjects: NEUROFARMACOLOGIA, APOPTOSE, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ, Matheus et al. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, v. 140, p. 201-208, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2018.08.009. Acesso em: 18 nov. 2024.
APA
Perez, M., Cartarozzi, L. P., Chiarotto, G. B., Oliveira, S. A. de, Guimarães, F. S., & Oliveira, A. L. R. de. (2018). Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. Neuropharmacology, 140, 201-208. doi:10.1016/j.neuropharm.2018.08.009
NLM
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009
Vancouver
Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA de, Guimarães FS, Oliveira ALR de. Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative [Internet]. Neuropharmacology. 2018 ; 140 201-208.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2018.08.009
Artigo de periodico
P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice (2018)
Domingos, Luana Barreto ; Hott, Sara Cristina ; Terzian, Ana ; Moraes, Leonardo Resstel Barbosa
Source: Neuropharmacology. Unidade: FMRP
Subjects: NEUROFARMACOLOGIA, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOMINGOS, Luana Barreto et al. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice. Neuropharmacology, v. 128, p. 474-481, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2017.08.005. Acesso em: 18 nov. 2024.
APA
Domingos, L. B., Hott, S. C., Terzian, A., & Moraes, L. R. B. (2018). P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice. Neuropharmacology, 128, 474-481. doi:10.1016/j.neuropharm.2017.08.005
NLM
Domingos LB, Hott SC, Terzian A, Moraes LRB. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice [Internet]. Neuropharmacology. 2018 ; 128 474-481.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.08.005
Vancouver
Domingos LB, Hott SC, Terzian A, Moraes LRB. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice [Internet]. Neuropharmacology. 2018 ; 128 474-481.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.08.005
Artigo de periodico
Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours (2017)
Falconi-Sobrinho, Luiz Luciano; Garcia, Tayllon dos Anjos; Elias-Filho, Daoud Hibrahim; Coimbra, Norberto Cysne
Source: Neuropharmacology. Unidade: FMRP
Subjects: ANTAGONISTAS, MEDO, HIPOTÁLAMO, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALCONI-SOBRINHO, Luiz Luciano et al. Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours. Neuropharmacology, v. 113, p. 367-385, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2016.10.001. Acesso em: 18 nov. 2024.
APA
Falconi-Sobrinho, L. L., Garcia, T. dos A., Elias-Filho, D. H., & Coimbra, N. C. (2017). Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours. Neuropharmacology, 113, 367-385. doi:10.1016/j.neuropharm.2016.10.001
NLM
Falconi-Sobrinho LL, Garcia T dos A, Elias-Filho DH, Coimbra NC. Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours [Internet]. Neuropharmacology. 2017 ; 113 367-385.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.10.001
Vancouver
Falconi-Sobrinho LL, Garcia T dos A, Elias-Filho DH, Coimbra NC. Unravelling cortico-hypothalamic pathways regulating unconditioned fear-induced antinociception and defensive behaviours [Internet]. Neuropharmacology. 2017 ; 113 367-385.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.10.001
Artigo de periodico
CB 1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABA A receptor blockade in the dorsomedial division of the ventromedial hypothalamus (2017)
Garcia, Tayllon dos Anjos; Ullah, Farhad; Falconi-Sobrinho, Luiz Luciano; Coimbra, Norberto Cysne
Source: Neuropharmacology. Unidade: FMRP
Subjects: CANABINOIDES, COMPORTAMENTO DEFENSIVO ANIMAL, GABA, HIPOTÁLAMO, MODELOS ANIMAIS DE DOENÇAS, TRANSTORNO DO PÂNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Tayllon dos Anjos et al. CB 1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABA A receptor blockade in the dorsomedial division of the ventromedial hypothalamus. Neuropharmacology, v. 113, p. 156-166, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2016.04.003. Acesso em: 18 nov. 2024.
APA
Garcia, T. dos A., Ullah, F., Falconi-Sobrinho, L. L., & Coimbra, N. C. (2017). CB 1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABA A receptor blockade in the dorsomedial division of the ventromedial hypothalamus. Neuropharmacology, 113, 156-166. doi:10.1016/j.neuropharm.2016.04.003
NLM
Garcia T dos A, Ullah F, Falconi-Sobrinho LL, Coimbra NC. CB 1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABA A receptor blockade in the dorsomedial division of the ventromedial hypothalamus [Internet]. Neuropharmacology. 2017 ; 113 156-166.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.04.003
Vancouver
Garcia T dos A, Ullah F, Falconi-Sobrinho LL, Coimbra NC. CB 1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABA A receptor blockade in the dorsomedial division of the ventromedial hypothalamus [Internet]. Neuropharmacology. 2017 ; 113 156-166.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.04.003
Artigo de periodico
Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors (2017)
Stern, Cristina A. J.; Silva, Thiago R. da; Raymundi, Ana M.; Souza, Camila P. de; Sato, Vinicius A. Hiroaki; Kato, Luiza; Guimarães, Francisco Silveira; Andreatini, Roberto; Takahashi, Reinaldo N.; Bertoglio, Leandro J.
Source: Neuropharmacology. Unidade: FMRP
Subjects: CANABINOIDES, INIBIDORES DE ENZIMAS, MEDO, HIPOCAMPO, MEMÓRIA, FÁRMACOS PSICOTRÓPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STERN, Cristina A. J. et al. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors. Neuropharmacology, v. 125, p. 220-230, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2017.07.024. Acesso em: 18 nov. 2024.
APA
Stern, C. A. J., Silva, T. R. da, Raymundi, A. M., Souza, C. P. de, Sato, V. A. H., Kato, L., et al. (2017). Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors. Neuropharmacology, 125, 220-230. doi:10.1016/j.neuropharm.2017.07.024
NLM
Stern CAJ, Silva TR da, Raymundi AM, Souza CP de, Sato VAH, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors [Internet]. Neuropharmacology. 2017 ; 125 220-230.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.07.024
Vancouver
Stern CAJ, Silva TR da, Raymundi AM, Souza CP de, Sato VAH, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors [Internet]. Neuropharmacology. 2017 ; 125 220-230.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.07.024
Artigo de periodico
Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors (2017)
Sestile, Caio César; Maraschin, Jhonatan Christian; Gama, Vanessa Scalco; Zangrossi Júnior, Hélio; Graeff, Frederico Guilherme; Audi, Elisabeth Aparecida
Source: Neuropharmacology. Unidades: FMRP, FFCLRP
Subjects: INIBIDORES DE ENZIMAS, BRADICININA, PÂNICO, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL, SOMATOSTATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SESTILE, Caio César et al. Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors. Neuropharmacology, v. 123, p. 80-87, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2017.05.025. Acesso em: 18 nov. 2024.
APA
Sestile, C. C., Maraschin, J. C., Gama, V. S., Zangrossi Júnior, H., Graeff, F. G., & Audi, E. A. (2017). Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors. Neuropharmacology, 123, 80-87. doi:10.1016/j.neuropharm.2017.05.025
NLM
Sestile CC, Maraschin JC, Gama VS, Zangrossi Júnior H, Graeff FG, Audi EA. Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors [Internet]. Neuropharmacology. 2017 ; 123 80-87.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.05.025
Vancouver
Sestile CC, Maraschin JC, Gama VS, Zangrossi Júnior H, Graeff FG, Audi EA. Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors [Internet]. Neuropharmacology. 2017 ; 123 80-87.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.05.025
Artigo de periodico
The relevance of kalikrein-kinin system via activation of B2 receptor in LPS-induced fever in rats (2017)
Soares, Denis de Melo; Santos, Danielle R.; Rummel, Christoph; Ott, Daniela; Melo, Miriam Cristina Contin de; Roth, Joachim; Calixto, João B.; Souza, Glória Emília Petto de
Source: Neuropharmacology. Unidade: FCFRP
Subjects: ANIMAIS, PROSTAGLANDINAS, NEURÔNIOS, FEBRE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Denis de Melo et al. The relevance of kalikrein-kinin system via activation of B2 receptor in LPS-induced fever in rats. Neuropharmacology, v. 126, p. 84-96, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2017.08.019. Acesso em: 18 nov. 2024.
APA
Soares, D. de M., Santos, D. R., Rummel, C., Ott, D., Melo, M. C. C. de, Roth, J., et al. (2017). The relevance of kalikrein-kinin system via activation of B2 receptor in LPS-induced fever in rats. Neuropharmacology, 126, 84-96. doi:10.1016/j.neuropharm.2017.08.019
NLM
Soares D de M, Santos DR, Rummel C, Ott D, Melo MCC de, Roth J, Calixto JB, Souza GEP de. The relevance of kalikrein-kinin system via activation of B2 receptor in LPS-induced fever in rats [Internet]. Neuropharmacology. 2017 ; 126 84-96.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.08.019
Vancouver
Soares D de M, Santos DR, Rummel C, Ott D, Melo MCC de, Roth J, Calixto JB, Souza GEP de. The relevance of kalikrein-kinin system via activation of B2 receptor in LPS-induced fever in rats [Internet]. Neuropharmacology. 2017 ; 126 84-96.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2017.08.019
Artigo de periodico
Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats (2017)
Hott, Sara C.; Gomes, Felipe V.; Uliana, Daniela L.; Vale, Gabriel T.; Tirapelli, Carlos Renato ; Resstel, Leonardo Barbosa Moraes
Source: Neuropharmacology. Unidades: EERP, FMRP
Subjects: ÓXIDO NÍTRICO, SISTEMA CARDIOVASCULAR, GLUTAMATOS, MEDO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOTT, Sara C. et al. Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats. Neuropharmacology, v. 112, n. Pt. A, p. 135-143, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2016.05.022. Acesso em: 18 nov. 2024.
APA
Hott, S. C., Gomes, F. V., Uliana, D. L., Vale, G. T., Tirapelli, C. R., & Resstel, L. B. M. (2017). Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats. Neuropharmacology, 112( Pt. A), 135-143. doi:10.1016/j.neuropharm.2016.05.022
NLM
Hott SC, Gomes FV, Uliana DL, Vale GT, Tirapelli CR, Resstel LBM. Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats [Internet]. Neuropharmacology. 2017 ; 112( Pt. A): 135-143.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.05.022
Vancouver
Hott SC, Gomes FV, Uliana DL, Vale GT, Tirapelli CR, Resstel LBM. Bed nucleus of the stria terminalis NMDA receptors and nitric oxide modulate contextual fear conditioning in rats [Internet]. Neuropharmacology. 2017 ; 112( Pt. A): 135-143.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2016.05.022
Artigo de periodico
Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat (2014)
Fassini, Aline; Scopinho, América A; Resstel, Leonardo Barbosa Moraes; Corrêa, Fernando Morgan de Aguiar
Source: Neuropharmacology. Unidade: FMRP
Subjects: CÓRTEX CEREBRAL (FISIOPATOLOGIA), RECEPTORES (METABOLISMO), ESTRESSE PSICOLÓGICO, PRESSÃO SANGUÍNEA (EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FASSINI, Aline et al. Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat. Neuropharmacology, v. 85, p. 367-374, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2014.04.019. Acesso em: 18 nov. 2024.
APA
Fassini, A., Scopinho, A. A., Resstel, L. B. M., & Corrêa, F. M. de A. (2014). Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat. Neuropharmacology, 85, 367-374. doi:10.1016/j.neuropharm.2014.04.019
NLM
Fassini A, Scopinho AA, Resstel LBM, Corrêa FM de A. Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat [Internet]. Neuropharmacology. 2014 ; 85 367-374.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2014.04.019
Vancouver
Fassini A, Scopinho AA, Resstel LBM, Corrêa FM de A. Opioid receptors in the prelimbic cortex modulate restraint stress-induced cardiovascular responses in the rat [Internet]. Neuropharmacology. 2014 ; 85 367-374.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2014.04.019
Artigo de periodico
Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence (2012)
Montezuma, Karina; Biojone, Caroline; Lisboa, Sabrina Francesca; Cunha, Fernando de Queiroz; Guimarães, Francisco Silveira; Joca, Sâmia Regiane Lourenço
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ÓXIDO NÍTRICO, DEPRESSÃO, ESTRESSE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEZUMA, Karina et al. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence. Neuropharmacology, v. 62, n. 1, p. 485-491, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2011.09.004. Acesso em: 18 nov. 2024.
APA
Montezuma, K., Biojone, C., Lisboa, S. F., Cunha, F. de Q., Guimarães, F. S., & Joca, S. R. L. (2012). Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence. Neuropharmacology, 62( 1), 485-491. doi:10.1016/j.neuropharm.2011.09.004
NLM
Montezuma K, Biojone C, Lisboa SF, Cunha F de Q, Guimarães FS, Joca SRL. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence [Internet]. Neuropharmacology. 2012 ; 62( 1): 485-491.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2011.09.004
Vancouver
Montezuma K, Biojone C, Lisboa SF, Cunha F de Q, Guimarães FS, Joca SRL. Inhibition of iNOS induces antidepressant-like effects in mice: pharmacological and genetic evidence [Internet]. Neuropharmacology. 2012 ; 62( 1): 485-491.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2011.09.004
Artigo de periodico
5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray (2011)
Yamashita, Paula Shimene de Melo; Bortoli, Valquíria Camin de; Zangrossi Junior, Helio
Source: Neuropharmacology. Unidade: FMRP
Subjects: FÁRMACOS, RECEPTORES, PÂNICO, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMASHITA, Paula Shimene de Melo e BORTOLI, Valquíria Camin de e ZANGROSSI JUNIOR, Helio. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray. Neuropharmacology, v. 60, n. 2-3, p. 216-222, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2010.09.001. Acesso em: 18 nov. 2024.
APA
Yamashita, P. S. de M., Bortoli, V. C. de, & Zangrossi Junior, H. (2011). 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray. Neuropharmacology, 60( 2-3), 216-222. doi:10.1016/j.neuropharm.2010.09.001
NLM
Yamashita PS de M, Bortoli VC de, Zangrossi Junior H. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray [Internet]. Neuropharmacology. 2011 ; 60( 2-3): 216-222.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2010.09.001
Vancouver
Yamashita PS de M, Bortoli VC de, Zangrossi Junior H. 5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray [Internet]. Neuropharmacology. 2011 ; 60( 2-3): 216-222.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.neuropharm.2010.09.001

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration